Taking a Second Look at Neoadjuvant Endocrine Therapy for the Treatment of Early Stage Estrogen Receptor Positive Breast Cancer During the COVID-19 Outbreak.

Thompson, Carlie K; Lee, Minna K; Baker, Jennifer L; Attai, Deanna J; DiNome, Maggie L

Thompson, Carlie K; Lee, Minna K; Baker, Jennifer L; Attai, Deanna J; DiNome, Maggie L.

Thompson CK; Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, CA 90095.

Ann Surg ; 272(2): e96-e97, 2020 08.

Article in English | MEDLINE | ID: covidwho-707350

Subject(s)

Antineoplastic Agents, Hormonal/therapeutic use; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Coronavirus Infections/epidemiology; Pneumonia, Viral/epidemiology; Receptors, Estrogen/metabolism; Betacoronavirus; Biomarkers, Tumor/analysis; Breast Neoplasms/metabolism; Breast Neoplasms/surgery; COVID-19; Chemotherapy, Adjuvant; Female; Humans; Neoadjuvant Therapy; Neoplasm Staging; Pandemics; SARS-CoV-2; Triage

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Receptors, Estrogen / Coronavirus Infections / Antineoplastic Agents, Hormonal Type of study: Observational study Limits: Female / Humans Language: English Journal: Ann Surg Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google